Cargando…

Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone

BACKGROUND: Opioid use disorders (OUDs) have devastating effects on individuals, families, and communities. While medication treatments for OUD save lives and are increasingly utilized, rates of treatment dropout are very high. In addition, most existing medication treatments for OUD may often negle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osilla, Karen Chan, Becker, Kirsten, Ecola, Liisa, Hurley, Brian, Manuel, Jennifer K., Ober, Allison, Paddock, Susan M., Watkins, Katherine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353769/ https://www.ncbi.nlm.nih.gov/pubmed/32653029 http://dx.doi.org/10.1186/s13722-020-00199-2

Ejemplares similares

Demographic and Mental Health Characteristics of Individuals Who Present to Community Health Clinics With Substance Misuse
por: Iyiewuare, Praise O., et al.
Publicado: (2017)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
por: Hansen, Brenna, et al.
Publicado: (2022)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

A pilot study comparing in-person and web-based motivational interviewing among adults with a first-time DUI offense
por: Osilla, Karen Chan, et al.
Publicado: (2015)

Continuous quality improvement (CQI) in addiction treatment settings: design and intervention protocol of a group randomized pilot study
por: Hunter, Sarah B, et al.
Publicado: (2014)

Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone
por: Arhin, Martin, et al.
Publicado: (2023)

Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial
por: Wong, James S. H., et al.
Publicado: (2021)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone
por: Lander, Laura, et al.
Publicado: (2017)

Sexual dysfunction in men on buprenorphine – naloxone-based substitution therapy
por: Mattoo, Surendra K., et al.
Publicado: (2020)

Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
por: Kunøe, Nikolaj, et al.
Publicado: (2016)

The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder
por: Ober, Allison J., et al.
Publicado: (2022)

Use of a sequential multiple assignment randomized trial to test contingency management and an integrated behavioral economic and mindfulness intervention for buprenorphine-naloxone medication adherence for opioid use disorder
por: Peter, Samuel C., et al.
Publicado: (2023)

Study design to evaluate cognitive behavioral therapy among a diverse sample of adults with a first-time DUI offense
por: Osilla, Karen Chan, et al.
Publicado: (2016)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
por: Barry, Declan T., et al.
Publicado: (2007)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
por: Ordean, Alice, et al.
Publicado: (2023)

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
por: Ellerbroek, Hannah, et al.
Publicado: (2022)

Motivational network intervention to reduce substance use and increase supportive connections among formerly homeless emerging adults transitioning to housing: study protocol for a pilot randomized controlled trial
por: Tucker, Joan S., et al.
Publicado: (2021)

Assessing and improving organizational readiness to implement substance use disorder treatment in primary care: findings from the SUMMIT study
por: Ober, Allison J., et al.
Publicado: (2017)

Evaluation of buprenorphine/naloxone dose and use of sedating supportive medication on treatment outcomes in veterans with opioid use disorder
por: Kapuganti, Amber, et al.
Publicado: (2018)

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
por: Regenstreif, Lori, et al.
Publicado: (2022)

Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
por: Tofighi, Babak, et al.
Publicado: (2014)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
por: Jumah, Naana Afua, et al.
Publicado: (2016)

Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
por: Norton, Merrill, et al.
Publicado: (2016)

823 Evaluation of Drug-Drug Interaction between Asunaprevir and Methadone or Buprenorphine/Naloxone
por: Garimella, Tushar, et al.
Publicado: (2014)

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
por: Kulaksızoğlu, Burak, et al.
Publicado: (2018)

Validated Spectrophtometric Method for Simultaneous Determination of Buprenorphine and Naloxone in Pharmaceutical Dosage Forms
por: Souri, Effat, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m8mmpisfh5f31cr1kdkorkqelb